Genexine Stock Cash Per Share
| 095700 Stock | KRW 5,880 230.00 4.07% |
Genexine fundamentals help investors to digest information that contributes to Genexine's financial success or failures. It also enables traders to predict the movement of Genexine Stock. The fundamental analysis module provides a way to measure Genexine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genexine stock.
Genexine |
Genexine Company Cash Per Share Analysis
Genexine's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Genexine Cash Per Share | 687.14 X |
Most of Genexine's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genexine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Genexine has a Cash Per Share of 687 times. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The cash per share for all Republic of Korea stocks is notably lower than that of the firm.
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Genexine Fundamentals
| Return On Equity | -10.06 | |||
| Return On Asset | -0.0172 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 2.14 T | |||
| Shares Outstanding | 20.55 M | |||
| Shares Owned By Insiders | 21.02 % | |||
| Shares Owned By Institutions | 7.17 % | |||
| Price To Sales | 10.84 X | |||
| Revenue | 36.83 B | |||
| Gross Profit | 9.76 B | |||
| EBITDA | (14.76 B) | |||
| Net Income | (48.56 B) | |||
| Cash And Equivalents | 27.8 B | |||
| Cash Per Share | 687.14 X | |||
| Total Debt | 40.79 B | |||
| Debt To Equity | 31.90 % | |||
| Current Ratio | 2.26 X | |||
| Book Value Per Share | 3,270 X | |||
| Cash Flow From Operations | (12.75 B) | |||
| Earnings Per Share | (1,283) X | |||
| Target Price | 121750.0 | |||
| Number Of Employees | 123 | |||
| Beta | 0.88 | |||
| Market Capitalization | 318.55 B | |||
| Total Asset | 636.86 B | |||
| Retained Earnings | (28.44 B) | |||
| Working Capital | 6.5 B | |||
| Current Asset | 11.66 B | |||
| Current Liabilities | 5.16 B | |||
| Z Score | 4.2 | |||
| Net Asset | 636.86 B |
About Genexine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genexine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genexine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genexine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Genexine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genexine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genexine will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Genexine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genexine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genexine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genexine to buy it.
The correlation of Genexine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genexine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genexine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genexine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genexine Stock
Genexine financial ratios help investors to determine whether Genexine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genexine with respect to the benefits of owning Genexine security.